MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling

Xin Zhou(Guiyang Medical University), Tao Peng(First Affiliated Hospital of GuangXi Medical University)
Cell Death Discovery
October 15, 2022
Cited by 51


Related Papers